|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Federal funds sold and other interest-bearing deposits | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Certificates of deposit in other banks | ||||||||||||||||||||
| Securities held to maturity, at cost | ||||||||||||||||||||
| Securities held to maturity, at amortized cost less allowance for credit losses of $62.5 and $60.0 | ||||||||||||||||||||
| Securities available for sale, at fair value | ||||||||||||||||||||
| Securities held to maturity, at amortized cost less allowance for credit losses of $63 and $79 | ||||||||||||||||||||
| Equity security, at fair value | ||||||||||||||||||||
| Restricted stock, at cost | ||||||||||||||||||||
| Mortgage loans held for sale | ||||||||||||||||||||
| Loans, less allowance for credit losses of $4,304 and $4,260 | ||||||||||||||||||||
| Loans, less allowance for credit losses of $4,518 and $4,361 | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Other real estate owned, net | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Goodwill and other intangibles, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Securities sold under repurchase agreements | ||||||||||||||||||||
| Federal Home Loan Bank of Atlanta advances | ||||||||||||||||||||
| Federal Reserve Bank advances | ||||||||||||||||||||
| Long-term debt, net of issuance costs | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||||
| Common stock, par value $.01 per share, authorized 5,000,000 shares; issued and outstanding 3,262,958 shares in 2026 and 3,229,795 shares in 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
